Europe Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)
The Europe stem cell therapy market was valued at US$ 446.75 million in 2022 and is projected to reach US$ 1,209.01 million by 2028; it is expected to grow at a CAGR of 18.0% from 2022 to 2028.
Growing Prevalence of Cancer is Driving the Europe Stem Cell Therapy Market
Cancer is one of the leading causes of mortality across the world, and the disease is profoundly affecting the quality of life. The National Cancer Institute report also states that stem cell transplants assist in the restoration of blood-forming cells among cancer patients undergoing chemotherapy or radiation therapy. Blood-forming stem cells are important as they facilitate the growth of different types of blood cells, such as white blood cells (WBCs), red blood cells (RBCs), and platelets. The stem cell transplants do not function directly against cancer; instead, they help recover the body's ability to produce stem cells after treatment with high doses of radiation therapy, chemotherapy, or both. Thus, an increase in the demand for advanced cancer treatment is driving the growth of the Europe stem cell therapy market.
Europe Stem Cell Therapy Market Overview
The European stem cell therapy market is divided into Germany, the UK, France, Italy, and Spain. Countries such as Germany and the UK are expected to be the largest contributor to the stem cell therapy market due to increasing prevalence chronic conditions, growing awareness of stem cell therapies, and extensive research & development activities. Additionally, rapidly developing healthcare infrastructure in Southern Europe is projected to offer lucrative growth opportunity for Europe stem cell therapy market.
Major players and health organizations in Germany are involved in research and development activities for the development of stem cell therapies for the treatment of range of diseases. For instance, in July 2018, Viscofan BioEngineering, one of the leading stem cell therapy players in the market, announced that Spanish Agency for Medicines (AEMPS) approved its clinical phase I trial for regenerative medicine. The novel therapy will be intended to treat patients suffering from severe cardiac insufficiency. Additionally, the awareness of the benefits offered by stem cell therapies is increasing in the country. A significant number of research institutes are collaborating amongst themselves intending to develop a new range of therapies for chronic conditions. For instance, in October 2018, Fraunhofer research institute announced its collaboration with the Japanese Society for Regenerative Medicine. The duo agreed to develop new regenerative medicines, including stem cell therapies to cure diseases. Moreover, the organizations signed a memorandum of understanding to share research information, technologies, and regulatory developments with each other.
Exhibit: Europe Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)
Europe Stem Cell Therapy Market Segmentation
The Europe stem cell therapy market is segmented into type, treatment, application, end user, and country.
The Europe stem cell therapy market, by type, is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2022.
Based on treatment, the Europe stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the largest share of the market in 2022.
Based on application, the Europe stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The musculoskeletal segment held the largest share of the market in 2022.
The Europe stem cell therapy market, by end user, is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held the largest share of the market in 2022.
Based on country, the Europe stem cell therapy market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
MEDIPOST; BioTime, Inc.; Mesoblast Limited; TiGenix NV; Holostem Terapie Avanzate Srl; and NuVasive Inc are the leading companies operating in the Europe stem cell therapy market.
Growing Prevalence of Cancer is Driving the Europe Stem Cell Therapy Market
Cancer is one of the leading causes of mortality across the world, and the disease is profoundly affecting the quality of life. The National Cancer Institute report also states that stem cell transplants assist in the restoration of blood-forming cells among cancer patients undergoing chemotherapy or radiation therapy. Blood-forming stem cells are important as they facilitate the growth of different types of blood cells, such as white blood cells (WBCs), red blood cells (RBCs), and platelets. The stem cell transplants do not function directly against cancer; instead, they help recover the body's ability to produce stem cells after treatment with high doses of radiation therapy, chemotherapy, or both. Thus, an increase in the demand for advanced cancer treatment is driving the growth of the Europe stem cell therapy market.
Europe Stem Cell Therapy Market Overview
The European stem cell therapy market is divided into Germany, the UK, France, Italy, and Spain. Countries such as Germany and the UK are expected to be the largest contributor to the stem cell therapy market due to increasing prevalence chronic conditions, growing awareness of stem cell therapies, and extensive research & development activities. Additionally, rapidly developing healthcare infrastructure in Southern Europe is projected to offer lucrative growth opportunity for Europe stem cell therapy market.
Major players and health organizations in Germany are involved in research and development activities for the development of stem cell therapies for the treatment of range of diseases. For instance, in July 2018, Viscofan BioEngineering, one of the leading stem cell therapy players in the market, announced that Spanish Agency for Medicines (AEMPS) approved its clinical phase I trial for regenerative medicine. The novel therapy will be intended to treat patients suffering from severe cardiac insufficiency. Additionally, the awareness of the benefits offered by stem cell therapies is increasing in the country. A significant number of research institutes are collaborating amongst themselves intending to develop a new range of therapies for chronic conditions. For instance, in October 2018, Fraunhofer research institute announced its collaboration with the Japanese Society for Regenerative Medicine. The duo agreed to develop new regenerative medicines, including stem cell therapies to cure diseases. Moreover, the organizations signed a memorandum of understanding to share research information, technologies, and regulatory developments with each other.
Exhibit: Europe Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)
Europe Stem Cell Therapy Market Segmentation
The Europe stem cell therapy market is segmented into type, treatment, application, end user, and country.
The Europe stem cell therapy market, by type, is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2022.
Based on treatment, the Europe stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the largest share of the market in 2022.
Based on application, the Europe stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The musculoskeletal segment held the largest share of the market in 2022.
The Europe stem cell therapy market, by end user, is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held the largest share of the market in 2022.
Based on country, the Europe stem cell therapy market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2022.
MEDIPOST; BioTime, Inc.; Mesoblast Limited; TiGenix NV; Holostem Terapie Avanzate Srl; and NuVasive Inc are the leading companies operating in the Europe stem cell therapy market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Stem Cell Therapy Market – By Type
1.3.2 Europe Stem Cell Therapy Market – By Treatment
1.3.3 Europe Stem Cell Therapy Market – By Application
1.3.4 Europe Stem Cell Therapy Market – By End User
1.3.5 Europe Stem Cell Therapy Market – By Country
2. EUROPE STEM CELL THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE STEM CELL THERAPY MARKET– MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. EUROPE STEM CELL THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. STEM CELL THERAPY MARKET – EUROPE ANALYSIS
6.1 Europe Stem Cell Therapy Market Revenue Forecast and Analysis
7. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Europe Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY TREATMENT
8.1 Overview
8.2 Europe Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
9.1 Overview
9.2 Europe Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
10.1 Overview
10.2 Europe Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
11.1 Overview
11.1.1 Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.3.1 Germany: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.1.4 Germany: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.1.5 Germany: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.1.6 Germany: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 UK: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.3.1 UK: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.2.4 UK: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.2.5 UK: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.2.6 UK: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.3 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 France: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.3.1 France: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.3.4 France: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.3.5 France: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.3.6 France: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.4 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.4.3.1 Italy: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.4.4 Italy: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.4.5 Italy: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.4.6 Italy: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.5 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.5.3.1 Spain: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.5.4 Spain: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.5.5 Spain: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.5.6 Spain: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.6 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.6.3.1 Rest of Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
12. STEM CELL THERAPY MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Stem Cell Therapy Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 MEDIPOST
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BioTime, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mesoblast Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Holostem Terapie Avanzate Srl
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 TiGenix NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 NuVasive Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Stem Cell Therapy Market – By Type
1.3.2 Europe Stem Cell Therapy Market – By Treatment
1.3.3 Europe Stem Cell Therapy Market – By Application
1.3.4 Europe Stem Cell Therapy Market – By End User
1.3.5 Europe Stem Cell Therapy Market – By Country
2. EUROPE STEM CELL THERAPY MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. EUROPE STEM CELL THERAPY MARKET– MARKET LANDSCAPE
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. EUROPE STEM CELL THERAPY MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management
5.1.2 Growing Prevalence of Cancer
5.2 Market Restraints
5.2.1 Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments
5.3 Market Opportunities
5.3.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines
5.4 Future Trends
5.4.1 Research Activities and Product Innovations
5.5 Impact Analysis
6. STEM CELL THERAPY MARKET – EUROPE ANALYSIS
6.1 Europe Stem Cell Therapy Market Revenue Forecast and Analysis
7. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY TYPE
7.1 Overview
7.2 Europe Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
7.3 Adult Stem Cell Therapy
7.3.1 Overview
7.3.2 Adult Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Hematopoietic Stem Cell Therapy
7.3.3.1 Overview
7.3.3.2 Hematopoietic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Umbilical Cord Stem Cell Therapy
7.3.4.1 Overview
7.3.4.2 Umbilical Cord Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Neuronal Stem Cell Therapy
7.3.5.1 Overview
7.3.5.2 Neuronal Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Mesenchymal Stem Cell
7.3.6.1 Overview
7.3.6.2 Mesenchymal Stem Cell: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Embryonic Stem Cell Therapy
7.4.1 Overview
7.4.2 Embryonic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Induced Pluripotent Stem Cell Therapy
7.5.1 Overview
7.5.2 Induced Pluripotent Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Other Stem Cell Therapy
7.6.1 Overview
7.6.2 Other Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8. EUROPE STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY TREATMENT
8.1 Overview
8.2 Europe Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
8.3 Allogeneic
8.3.1 Overview
8.3.2 Allogeneic: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Autologous
8.4.1 Overview
8.4.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9. EUROPE STEM CELL THERAPY MARKET ANALYSIS AND FORECASTS TO 2028 – BY APPLICATION
9.1 Overview
9.2 Europe Stem Cell Therapy Market, by Application 2021 & 2028 (%)
9.3 Musculoskeletal
9.3.1 Overview
9.3.2 Musculoskeletal: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Dermatology
9.4.1 Overview
9.4.2 Dermatology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Drug Discovery and Development
9.6.1 Overview
9.6.2 Drug Discovery and Development: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – BY END USER
10.1 Overview
10.2 Europe Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
10.3 Academic & Research Institutes
10.3.1 Overview
10.3.2 Academic & Research Institutes: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Hospitals & Specialty Clinics
10.4.1 Overview
10.4.2 Hospitals & Specialty Clinics: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11. EUROPE STEM CELL THERAPY MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
11.1 Overview
11.1.1 Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.1.3.1 Germany: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.1.4 Germany: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.1.5 Germany: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.1.6 Germany: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 UK: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.2.3.1 UK: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.2.4 UK: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.2.5 UK: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.2.6 UK: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.3 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 France: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.3.3.1 France: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.3.4 France: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.3.5 France: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.3.6 France: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.4 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.4.3.1 Italy: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.4.4 Italy: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.4.5 Italy: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.4.6 Italy: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.5 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.5.3.1 Spain: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.5.4 Spain: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.5.5 Spain: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.5.6 Spain: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
11.1.1.6 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)
11.1.1.6.3.1 Rest of Europe: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)
12. STEM CELL THERAPY MARKET–INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Stem Cell Therapy Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. COMPANY PROFILES
13.1 MEDIPOST
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BioTime, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mesoblast Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Holostem Terapie Avanzate Srl
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 TiGenix NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 NuVasive Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Cost Expenditure of Stem Cell Injection
Table 2. Germany Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. UK Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Organic Developments in the Stem Cell Therapy Market
Table 33. Inorganic Developments in the Stem Cell Therapy Market
Table 34. Glossary of Terms
Table 1. Cost Expenditure of Stem Cell Injection
Table 2. Germany Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11. UK Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 14. France Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21. Italy Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 25. Spain Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 26. Spain Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)
Table 29. Rest of Europe Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 30. Rest of Europe Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 32. Organic Developments in the Stem Cell Therapy Market
Table 33. Inorganic Developments in the Stem Cell Therapy Market
Table 34. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Stem Cell Therapy Market Segmentation
Figure 2. Europe Stem Cell Therapy Segmentation, By Country
Figure 3. Europe Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Europe Stem Cell Therapy Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. Europe PEST Analysis
Figure 8. Experts Opinion
Figure 9. Europe Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Europe Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 12. Adult Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematopoietic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Umbilical Cord Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Neuronal Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Mesenchymal Stem Cell: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Embryonic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Induced Pluripotent Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 21. Allogeneic: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 24. Musculoskeletal: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Dermatology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Drug Discovery and Development: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Other Applications: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 30. Academic & Research Institutes: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals & Specialty Clinics: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 34. Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Growth Strategies in the Stem Cell Therapy Market (%)
Figure 1. Europe Stem Cell Therapy Market Segmentation
Figure 2. Europe Stem Cell Therapy Segmentation, By Country
Figure 3. Europe Stem Cell Therapy Market Overview
Figure 4. Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Europe Stem Cell Therapy Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 7. Europe PEST Analysis
Figure 8. Experts Opinion
Figure 9. Europe Stem Cell Therapy Market Impact Analysis of Drivers and Restraints
Figure 10. Europe Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028
Figure 11. Europe Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)
Figure 12. Adult Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hematopoietic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Umbilical Cord Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Neuronal Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Mesenchymal Stem Cell: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Embryonic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Induced Pluripotent Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Other Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)
Figure 21. Allogeneic: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Stem Cell Therapy Market, by Application 2021 & 2028 (%)
Figure 24. Musculoskeletal: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Dermatology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiology: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Drug Discovery and Development: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Other Applications: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)
Figure 30. Academic & Research Institutes: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Hospitals & Specialty Clinics: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)
Figure 33. Europe: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)
Figure 34. Germany: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. UK: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. France: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Italy: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Spain: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of Europe: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Growth Strategies in the Stem Cell Therapy Market (%)
